Effectivity and Safety of Combination Cream of Salicylic Acid,Aqua Posae Filiformis,Niacinamide,Lipohydroxy Acid,Procerad,and Zinc PCA

• Status: Recruiting
• Trial end date: 2022-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

This clinical study will compare the effectivity and safety of combination cream of Salicylic Acid, Aqua Posae Filiformis, Niacinamide, Lipohydroxy Acid, Procerad, and Zinc PCA as adjuvant therapy for acne vulgaris patients. These combination cream will be tested by mild to moderate acne vulgaris patients. Participants will be female patients aged 15-50 years old and divided into three groups. The control group (Group 1) will use Adapalene 0.1% cream only every night. Group 2 will use Adapalene 0.1% cream intermittently every two nights and the combination cream every morning. Group 3 will use Adapalene 0.1% cream every night and the combination cream every morning.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Dr.dr.Irma Bernadette, SpKK (K)
• Treatments: Adapalene

Criteria

Inclusion Criteria:

• Female aged 15 - 50 years

• Mild and moderate acne vulgaris according to IAEM and GEA.

• Patients are willing to participate in the study until it is finished.

Exclusion Criteria:

• History of allergy to dermatocosmetic products.

• Undergoing other acne therapy, medication, or invasive action in the last month.

• Pregnant or breastfeeding patients